Hormonal Contraceptives Market
- 2026 年市場規模
- USD 17.9 Bn
- 2033 年預估規模
- USD 23.7 Bn
- 年複合成長率 CAGR
- 5.2%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Hormonal Contraceptives Market, By Product (Oral Contraceptive Pills, Injectable Birth Control, Emergency Contraceptive Pills, Vaginal Ring, and Transdermal Patches), By Hormone (Progestin Only Contraceptive and Combined Hormonal Contraceptive), By Age Group (1524 Years, 2534 Years, 3544 Years, and Above 44 Years), By End User (Hospitals, Homecare, Gynecology Centers, Clinics, and Ambulatory Surgical Centers), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Hormonal contraception is one of the contraceptive methods that act on the endocrine system. Several types of female hormones are used to prevent ovulation and avoid fertilization. Hormonal contraception can also cause changes in the uterus, making pregnancy less likely. Based on product, the market is segmented into oral contraceptive pills, injectable birth control, emergency contraceptive pills, vaginal ring and transdermal patches. These are safe and reliable forms of hormonal contraceptives to prevent pregnancy. Hormonal contraception has several potential benefits such as they can reduce the risk of uterine cancer, ovarian cancer, and colon cancer. They generally reduce menstrual (menstrual) blood flow. They can reduce painful periods and are very effective in preventing pregnancy.
Market Dynamics
Increased awareness about the benefits and use of contraceptives is a major factor driving the global hormonal contraceptives market. The ever-increasing global population, particularly in developing economies such as India, Brazil, China and others, is a growing source of concern around the world, necessitating government initiatives such as public awareness campaigns to eliminate or reduce the risk of unwanted pregnancies, abortion risks, and the threat of sexual disorders. For instance, according to data from the World Health Organization (WHO), 16 million girls between the ages of 15 and 19 give birth each year, which represents approximately 11% of all births in the world. To prevent these unintended births, the World Health Organization have launched global awareness programs such as This is your life, this is your future. The London Family Planning Summit urged governments, international agencies and other private sectors to commit to improving the accessibility of voluntary family planning.
Key features of the study
• This report provides in-depth analysis of the global hormonal contraceptives market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2026-2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global hormonal contraceptives market based on the following parameters – company highlights, types portfolio, key highlights, financial performance, and market strategies
• Key companies covered as a part of this study include The Female Health Company, Teva Pharmaceutical Industries Limited, Bayer AG, Pfizer, Inc., Mylan N.V., Johnson & Johnson, Ansell Ltd., Mayer Laboratories, Merck & Co., Inc., Church & Dwight, Co., Inc., Afaxys, Inc., Allergan plc., Agile Therapeutics, Apothecus Pharmaceutical Corporation., Novartis AG, Sun Pharmaceutical Industries Ltd., and Cipla Limited.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global hormonal contraceptives market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hormonal contraceptives market
Market Segmentation
• By Product (Revenue, USD Bn, 2021-2033)
o Oral Contraceptive Pills
o Injectable Birth Control
o Emergency Contraceptive Pills
o Vaginal Ring
o Transdermal Patches
• By Hormone (Revenue, USD Bn, 2021-2033)
o Progestin Only Contraceptive
o Combined Hormonal Contraceptive
• By Age Group (Revenue, USD Bn, 2021-2033)
o 15–24 Years
o 25–34 Years
o 35–44 Years
o Above 44 Years
• By End User (Revenue, USD Bn, 2021-2033)
o Hospitals
o Homecare
o Gynecology Centers
o Clinics
o Ambulatory Surgical Centers
• By Region (Revenue, USD Bn, 2021-2033)
o North America
U.S.
Canada
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
South Africa
Central Africa
North Africa
• Key Players
o The Female Health Company
o Teva Pharmaceutical Industries Limited
o Bayer AG
o Pfizer, Inc.
o Mylan N.V.
o Johnson & Johnson
o Ansell Ltd.
o Mayer Laboratories
o Merck & Co., Inc.
o Church & Dwight, Co., Inc.
o Afaxys, Inc.
o Allergan plc.
o Agile Therapeutics
o Apothecus Pharmaceutical Corporation.
o Novartis AG
o Sun Pharmaceutical Industries Ltd.
o Cipla Limited.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Product
Market Snapshot, By Hormone
Market Snapshot, By Age Group
Market Snapshot, By End User
Market Snapshot, By Region
Market Opportunity Map
3. Global Hormonal Contraceptives Market Insights
o Drivers
o Restraints
o Opportunity
o Impact Analysis
o Pipeline Analysis
o Market Trends
o Product Launches
o Key Developments
o Regulatory Scenario
o Reimbursement Scenario
o Merger and Acquisition
o Epidemiology
o PEST Analysis
o SWOT Analysis
4. Global Hormonal Contraceptives Market, By Product, 2021-2033 (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022-2033
Segment Trends
o Oral Contraceptive Pills
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)
o Injectable Birth Control
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)
o Emergency Contraceptive Pills
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)
o Vaginal Ring
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)
o Transdermal Patches
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)
5. Global Hormonal Contraceptives Market, By Hormone, 2021-2033 (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022-2033
Segment Trends
o Progestin Only Contraceptive
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)
o Combined Hormonal Contraceptive
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)
6. Global Hormonal Contraceptives Market, By Age Group, 2021-2033 (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022-2033
Segment Trends
o 15–24 Years
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)
o 25–34 Years
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn
o 35–44 Years
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)
o Above 44 Years
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)
7. Global Hormonal Contraceptives Market, By End User, 2021-2033 (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022-2033
Segment Trends
o Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)
o Homecare
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn
o Gynecology Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn
o Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn
o Ambulatory Surgical Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)
8. Global Hormonal Contraceptives Market, By Region, 2021-2033 (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022-2033
Region at Trends
o North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Hormone, 2021-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Hormone, 2021-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Hormone, 2021-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Hormone, 2021-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Hormone, 2021-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
o GCC
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Hormone, 2021-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
Market Size and Forecast By Value, and Y-o-Y Growth, By Country/Region, 2021-2033, (USD Bn)
o South Africa
o Central Africa
o North Africa
9. Competitive Snapshot
o Company Profiles
The Female Health Company
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Teva Pharmaceutical Industries Limited
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Bayer AG
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Pfizer, Inc.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Mylan N.V.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Johnson & Johnson
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Ansell Ltd.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Mayer Laboratories
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Merck & Co., Inc.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Church & Dwight, Co., Inc.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Afaxys, Inc.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Allergan plc.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Agile Therapeutics
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Apothecus Pharmaceutical Corporation.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Novartis AG
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Sun Pharmaceutical Industries Ltd.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Cipla Limited
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
10. Section
o Research Methodology
o About us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們